Managing a patient with advanced isolated proctitis, a subtype of ulcerative colitis

Optimizing advanced therapy for moderate to severe ulcerative colitis

Positioning of new S1P receptor modulators to optimize patient outcomes in UC

C. diff: FMT and new microbiome therapies

JAK Inhibitors for Ulcerative Colitis: Conversations From the Clinic